Bayer eyes another slim-down sale; Chinese drugmaker suspends VA production;

@FiercePharma: Japan's Riken plans trial on transplanting stem cells of unrelated donors. FiercePharmaAsia article | Follow @FiercePharma

@EricPFierce: India's Micro Labs, whose Bangalore plant was banned by FDA, is recalling simvastatin made at Goa facility. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: We're back with #FierceMadness Round 3 today. Did you miss us? More at FiercePharmaMarketing | Follow @CarlyHFierce

> Bayer is weighing options for its consumer garden products as it prepares to split off its plastics business and merge its CropScience and HealthCare units. Report

> A Chinese drugmaker is suspending production at a plant in Virginia until business conditions improve. Report

> South Korea's antitrust regulator ordered Bayer's Korean unit to sell a contraceptive product, Mercilon, that it gained in a recent portfolio buy from Merck ($MRK). Report

> EUSA Pharma is now officially reborn, with a portfolio of specialty drugs bought from Jazz Pharmaceuticals ($JAZZ); CEO Bryan Morton founded the original EUSA, which sold to Jazz in 2012. Release

Medical Device News

@FierceMedDev: ICYMI: Sebacia reveals positive data for acne-fighting gold microparticle device. Article | Follow @FierceMedDev

@VarunSaxena2: DOJ cracks down on devicemakers in 2014 with $100M+ in fines. Editor's corner | Follow @VarunSaxena2

@EmilyWFierce: Highlight of my Monday: Foundation Medicine's new president and COO is named Kafka. Release | Follow @EmilyWFierce

> Edwards-backed CardioKinetix reports China heart failure data, US pivotal results expected in 2016. Article

> ReWalk Robotics stumbles 6 months after IPO. Story

Biotech News

@FierceBiotech: In a squeaker, FierceBiotech readers warn of a biotech bubble. Editor's corner | Follow @FierceBiotech

@JohnCFierce: Is it important that Biogen dropped Idec? No. Will everyone comment on it? Yes. News is funny that way. More | Follow @JohnCFierce

@DamianFierce: Auxogyn is a really good name for an IVF company, imo. FierceMedicalDevices story | Follow @DamianFierce

> Seventure adds €25M to microbiome investment fund. Story

> MEI's second go at cancer R&D flunks a Phase II MDS trial. More

> FDA removes the brakes on Pfizer and Lilly's pain drug. Report

Animal Health News

> Integrated Animal Health forms 10-year research pact with NMSU on herd health. More

> 3D Systems preps for global launch of 'printed' knee implants for dogs. Article

> Researchers examine role of dog ownership on beneficial bacteria. Item

> VCA division Antech buys Abaxis vet-lab assets for $21M. News

> Wild birds to blame for avian flu outbreak? Not so fast, say scientists. Story

Biotech IT News

> Cloud Pharmaceuticals allies with U. of Florida to advance in silico pipeline. News

> FDA under pressure to establish staff social media policy. More

> Big Pharma nervously eying Apple and Google's healthcare pitches. Item

> India crowdsources whistleblowing with website, mobile app. Story

> AstraZeneca taps Assay Depot to create preclinical service hub. Report

And Finally... Where Medicaid has expanded, doctors are identifying more cases of diabetes. Report

Suggested Articles

Novartis and Civica Rx are patterning up to shore up supply of six key generic injectables used in acute care settings in hospitals.

EU health commissioner Stella Kyriakides reportedly spoke with Gilead execs to iron out a deal to secure remdesivir supply for 16 EU countries.

Under a $1.6 billion deal with the U.S. government, Novavax has pledged to start producing 100 million doses of a COVID-19 vaccine later this year.